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Abstract
Background: Osteoarthritis (OA) has a high prevalence in primary care. Conservative, guideline orientated approaches aiming
at improving pain treatment and increasing physical activity, have been proven to be effective in several contexts outside the
primary care setting, as for instance the Arthritis Self management Programs (ASMPs). But it remains unclear if these
comprehensive evidence based approaches can improve patients' quality of life if they are provided in a primary care setting.
Methods/Design: PraxArt is a cluster randomised controlled trial with GPs as the unit of randomisation. The aim of the study
is to evaluate the impact of a comprehensive evidence based medical education of GPs on individual care and patients' quality
of life. 75 GPs were randomised either to intervention group I or II or to a control group. Each GP will include 15 patients
suffering from osteoarthritis according to the criteria of ACR.
In intervention group I GPs will receive medical education and patient education leaflets including a physical exercise program.
In intervention group II the same is provided, but in addition a practice nurse will be trained to monitor via monthly telephone
calls adherence to GPs prescriptions and advices and ask about increasing pain and possible side effects of medication.
In the control group no intervention will be applied at all. Main outcome measurement for patients' QoL is the GERMAN-AIMS2-
SF questionnaire. In addition data about patients' satisfaction (using a modified EUROPEP-tool), medication, health care
utilization, comorbidity, physical activity and depression (using PHQ-9) will be retrieved.
Measurements (pre data collection) will take place in months I-III, starting in June 2005. Post data collection will be performed
after 6 months.
Discussion: Despite the high prevalence and increasing incidence, comprehensive and evidence based treatment approaches
for OA in a primary care setting are neither established nor evaluated in Germany. If the evaluation of the presented approach
reveals a clear benefit it is planned to provide this GP-centred interventions on a much larger scale.
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Background
Arthritis is a most frequent affection of joints and a com-
mon condition in general practice (roughly 60–80
patients per thousand cases with an average of 5.7 GP con-
tacts per quarter) [1,2]. The GP is the primary contact for
arthritis patients and the main care provider for most
patients. Previous studies, including our own qualitative
pilot study, have shown that arthritis related pain and fear
of increasingly reduced mobility represent the most
important burden for arthritis patients [3]. There was a
large general need for information among patients con-
cerning as for instance individual options to influence the
course of the disease [3,4]. GPs approaches to OA varied
widely and patient education concerning life style and
motivation for physical activity was mostly vague and
unsighted [5]. An important need for information about
evidence based pain management according to WHO-rec-
ommendations was detected among GPs. Several studies
underlined the effectiveness of complex interventions
with active patient involvement such as the "Arthritis-self-
management-programs" (ASMPs) in the US and Canada.
However, these programs generally take place outside of
medical care settings [6-9]. But even there is quite good
evidence for these interventions, the implementation of
these approaches in a primary care setting seems to be
accompanied with additional problems, while in these
setting less positive results were revealed in former studies
[10-12].
However, it still remains unclear what approach is the best
to implement evidence based treatment approaches into
daily practice [13]. Without a doubt different settings and
cultures of implementing knowledge have to be consid-
ered. In Germany quality circles are a well established
concept and several studies have proven their impact on
different outcome parameters as for instance on prescrip-
tions [14]. But previous studies revealed that the improve-
ment in care is mostly moderate if no additional strategies
are provided to improve the impact of the meetings for
GPs [13]. Regarding the field of chronic care and espe-
cially degenerative joint diseases, the involvement of prac-
tice nurses, as for instance to perform frequent telephone
calls, has shown to increase the patients' quality of life
[15]. It could be assumed that the impact on patients may
increase if the induced implementations on the patients'
level are frequently monitored by practice nurses.
Methods
Aim of the study
The study examines whether a multifaceted intervention
with evidence based medical education for GPs can
improve the quality of life of arthritis patients.
Scientific hypothesis
A targeted evidence based medical education for GPs on
osteoarthritis has no effect on the quality of life of patients
with degenerative joint diseases and their prescribed med-
ication. Monitoring GPs' prescriptions and advices for
lifestyle changes by monthly telephone calls of practice
assistants with a structured form is not superior.
The study content is guided by internationally available
evidence for arthritis therapy in General Practice. Due to
the lack of a German arthritis guideline an evidence based
review for arthritis care in General Practice will be com-
piled from European guidelines [7,9,16]. Subsequently a
preliminary guideline will be elaborated based on this
material. Additionally motivational strategies and com-
munication skills will be taught to GPs in order to
improve the implementation of life style changes.
Study design
The study is a (prospective) cluster-randomized, open,
three-armed intervention study. The design of a cluster
randomized study was chosen because this has optimal
internal validity (absence of confounders) while avoiding
contamination of interventions associated with patient
randomization.
Sample size
Sample size calculations for cluster randomized trials dif-
fer completely from sample size calculations for common
RCTs [17-19]. Based on the main outcome parameter
(QoL) and the main outcome-assessment instrument
(GERMAN-AIMS2-SF) [20], we performed a power calcu-
lation with the Cluster Randomization Sample Size Calcu-
lator ver.1.02 of the University of Aberdeen. Assuming an
effect size of 30 % (according to recommendations of
Guillemin et al. [21]), an ICC of 0.03 (based on previous
studies and on data available at the website of the Univer-
sity of Aberdeen [22]) a power of 90 % a mean of 2.7 and
a minimal difference to detect of 0.9 and a significance
level of 0.05, we have to include 14 patients in each of the
25 practices.
Recruitment of GPs and randomization
The GPs are the unit of randomization. They were eligible
for randomization if their practice had a contract with all
German insurances, so it is assured that patients of all
social levels have unlimited admission to the practice. If
they were working in a non-single-handed practice, it was
important that they had their own patients which could
clearly be allocated to them. In Germany most of GPs
work in single handed practices, but even if not, patients
frequently are treated by one specific GP in a practice, so
that these inclusion criteria will not represent a source of
bias, because only an absolute minority of practices will
not be eligible for inclusion due to these criteria. AboutBMC Public Health 2005, 5:77 http://www.biomedcentral.com/1471-2458/5/77
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500 GPs in the area of Baden-Wuerttemberg and Bavaria,
fulfilling inclusion criteria, were invited by a formal letter
of the Department of General Practice and Health services
Research of the University of Heidelberg, to participate in
the study. 120 GPs gave their written consent to partici-
pate in the study. Based on detailed information about the
practice and the GP, the inclusion criteria were checked.
No GP or no practice had to be excluded due to the inclu-
sion criteria. The 120 GPs were invited to information
meetings were the aim and the procedure of the study
were explained in detail. After the meeting, the 120 eligi-
ble GPs were put on a list with numbers from 1 to 120.
Out of this list, 75 GPs were randomized with SPSS ver-
sion 11.0 to one of the intervention groups or the control
group by an independent assistant who is not familiar to
one of the participating doctors.
Patient inclusion criteria
To be eligible for inclusion patients have to be adult and
diagnosed with gonarthritis or coxarthritis according to
the ACR criteria [23]. They will be identified by the fol-
lowing ICD-10 code in patients file: M 16.0–16.9 and M
17.0–17.5. Based on this process, participating practices
keep an alphabetic record of their patients. Patients from
this list are contacted in consecutive order of appearance
in the practice and informed about the option to partici-
pate in the study. After giving their written informed con-
sent they receive the questionnaire and a stamped
envelope with the postal address of the university. The
patients are asked to return this questionnaire in the enve-
lope to the university. Neither the GP nor the practice
team has any possibility to get knowledge of the patients'
answers.
Patient exclusion criteria
1. Insufficient German language skills.
2. Patients, who contacted the practice for emergencies
only or as a substitute practice.
Data collection
After giving their informed and written consent to partici-
pate in the study patients will receive a questionnaire
which is based on arthritis-related indicators and include
the GERMAN-AIMS2-SF [20], a revised version of the
EUROPEP-questionnaire[24], as well as items that assess
secondary outcome parameters as shown in table 1. The
envelopes are opened at the university by an independent
research assistant and immediately scanned with the "eyes
and hands ™ FORMS"-Software (Version 5) of Read Soft.
A TIF-file is generated out of each questionnaire to avoid
any data-manipulation and to ease data storage. The data
are transferred into the SPSS program (version 12.0).
Patients' information on medication and health care utili-
zation will be checked by three research assistants, visiting
each practice.
Outcome-Parameter
Table 1 displays the outcome parameters and associated
used instruments. The primary outcome is quality of life
assessed by the AIMS2-SF questionnaire, an internation-
ally validated instrument for the assessment of quality of
life among arthritis patients [21]. We have validated this
instrument for German general practice in a previous
study [20].
Secondary outcomes include
• Medication (evidence based use of NSAR, application of
WHO-recommendations); data retrieved from patients
chart
• Health Care utilization (referrals to orthopedists, imag-
ing, inpatient care, physiotherapy); data retrieved from
patients chart
• Physical activity (percentage of patients meeting CDC
criteria)
• Patient satisfaction (modified EUROPEP-questionnaire)
[25]
• Potential confounders are being detected (concurrent
depression may influence the potential motivational
change for more physical activity) by means of PHQ-9
[26].
These data will be compiled from patient questionnaires
and patients chart review. All instruments represent well
established and validated instruments. Measurements and
analysis will take place before intervention (pre-data-col-
lection) and 6 months later (post-data collection).
Table 1: Outcome-parameters and instruments of the study
Outcome-Parameter 
(Patient)
Instrument
Primary Outcome
Quality of life GERMAN-AIMS2-SF
Secondary outcome
Health care utilization questonnaire, retrospective chart review
Patient satisfaction modified EUROPEP
Physical activity 6 minutes walking, CDC-criteria, specific 
questions
Medication questionnaire, retrospective chart review
Confounder control
Mental comorbidity PHQ-9BMC Public Health 2005, 5:77 http://www.biomedcentral.com/1471-2458/5/77
Page 4 of 6
(page number not for citation purposes)
Intervention
1. Implementation strategy – aiming at the GP
The implementation strategy consists of two interactive
quality circle meetings of 3 hours including 12–13 partic-
ipating GPs (Intervention group I). These meetings have
three main contents: evidenced based treatment of oste-
oarthritis in a primary care setting, optimizing pain treat-
ment according to the WHO recommendations,
providing advanced motivation skills. Intervention group
II represents an "add-on" approach. GPs will participate
in meetings with the same content as GPs of intervention
group I. In addition to these meetings, practice assistants
will also participate in a course. During this course the
assistance is trained to call patients and provide an OA
specific telephone questionnaire which addresses to three
main topics: Side effects of the prescribed drugs,
Flow diagram of the progress through the phases of the study Figure 1
Flow diagram of the progress through the phases of the study.
Pre-Data-Measurement
75 Practices, 1125 Patients
Randomisation
Control group
25 GPs, 375 Patients
Intervention group I
25 GPs, 375 Patients
Intervention group II
25 GPs, 375 Patients
GP training
Monthly follow -up
Post-Data-Measurement
75 Practices, 1125 Patients
Analysis
GP trainingBMC Public Health 2005, 5:77 http://www.biomedcentral.com/1471-2458/5/77
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adherence to recommended physical activity and changes
in pain.
In both intervention groups, GPs will receive a summary
of evidence based treatments of OA in a primary care set-
ting. These information contains the recommendations of
the EULAR group for the treatment of OA and the infor-
mation provided by the German Medical Association
[7,9,16]. GPs will also receive two written patient leaflets.
Leaflet one provides information about the cause and the
treatment possibilities as well as coping strategies and
contact addresses of self help groups for the patients. Leaf-
let two provides a detailed exercise program, developed by
a German self help group, the "Deutsche Rheumaliga".
This leaflet contains pictures and a step by step exercise
program, even patients with severe OA can perform.
2. Clinical intervention
In intervention group II frequent telephone calls will be
provided by each practice. For this purpose an osteoarthri-
tis specific telephone questionnaire – the "ArthMol" tool
– has been developed in cooperation with the Depart-
ment of General Practice at Johann-Wolfgang Goethe-
University Clinic, Frankfurt am Main. GPs' assistants will
contact OA patients via telephone every four weeks and
complete a structured telephone form during the conver-
sation. The form contains items referring to pain, adher-
ence to prescriptions, the exercise program and possible
side effects of the medication. According to the urgency of
the information it is either directly reported to the GP or
transmitted during the following day.
There is no implementation strategy in the control group
(group III).
Timeframe of the study
The study team has already randomized the 75 out of the
initial recruited 120 GPs who have declared their willing-
ness to participate in the study and to accepted random
assignment to the different groups. The patient inclusion
and pre data collection will take place in months I-III, the
intervention (quality circles and telephone calls in group
II) will take place in months IV-X. Post data collection will
be performed in months X-XII.
Description of risks
Serious risks or undesired effects of questionnaires have
not been described in the literature. There are no specific
risks related to the study.
Ethical and legal aspects
Ethical principles
The study is being conducted in accordance with medical
professional codex and the Helsinki Declaration as of
1996 as well as the German Federal Data Security Law
(BDSG).
Study participation of patients is voluntary and can be
cancelled at any time without provision of reasons and
without negative consequences for their future medical
care.
Patient informed consent
Previous to study participation patients receive written
and spoken information about the content and extent of
the planned study; for instance about potential benefits
for their health and potential risks. In case of acceptance
they sign the informed consent form.
In case of study discontinuation all material will be
destroyed or the patient will be asked if he/she accepts
that existing material can be analyzed in the study.
Legal principles
Vote of the ethics committee
The study protocol was approved by the ethics committee
of the University of Heidelberg previous to the start of the
study in January 2005. Inclusion of patients/ participants
did not start unless there was a written and unrestricted
positive vote of the ethics committee. This vote was
received in March 2005 (approval number 021/2005).
Data security/ disclosure of original documents
The patient names and all other confidential information
fall under medical confidentiality rules and are treated
according to German Federal Data Security Law (BDSG).
The results of the patient questionnaires are not accessible
to the GPs. Questionnaires are directly mailed to the study
center by the patient.
All study related data and documents are stored on a pro-
tected central server of the Heidelberg University Clinic.
Only direct members of the internal study team can access
the respective files.
Intermediate and final reports are stored in the office of
the Department of General Practice and Health Services
Research at the Heidelberg University Clinic.
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